General Announcement::Certificate of Compliance issued by the SUKL for GPL Baddi manufacturing facility

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
16-Dec-2019 12:49:21
Status
New
Announcement Sub Title
Certificate of Compliance issued by the SUKL for GPL Baddi manufacturing facility
Announcement Reference
SG191216OTHRUXHH
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
16/12/2019 10:17:00
Description (Please provide a detailed description of the event in the box below)
Certificate of Compliance issued by the European regulator, SUKL, Czech Republic for Glenmark s Baddi manufacturing facility

Attachments

PR_SGX_16.12.2019_Signed.pdf
Total size =347K